Overview

The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects

Status:
Completed
Trial end date:
2007-09-21
Target enrollment:
Participant gender:
Summary
This A Three-Part Drug-Drug Interaction Study To Evaluate Effects of Casopitant On Dolasetron, Granisetron or Rosiglitazone When Co-Administered in Healthy Adults
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Casopitant
Dolasetron
Granisetron
Rosiglitazone